Unichem Laboratories Overview
- Year Founded
-
1944
- Status
-
Public
- Employees
-
2,153
- Stock Symbol
-
506690
- Investments
-
4
- Share Price
-
$9.94
- (As of Friday Closing)
Unichem Laboratories General Information
Description
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
Contact Information
Website
www.unichemlabs.comCorporate Office
- Prabhat Estate
- Off S.V.Road, Jogeshwari (West)
- Mumbai, Maharashtra 400102
- India
Corporate Office
- Prabhat Estate
- Off S.V.Road, Jogeshwari (West)
- Mumbai, Maharashtra 400102
- India
Unichem Laboratories Stock Performance
As of 29-Nov-2024, Unichem Laboratories’s stock price is $9.94. Its current market cap is $700M with 70.4M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.94 | $9.82 | $4.82 - $11.25 | $700M | 70.4M | 9.3K |
Unichem Laboratories Financials Summary
As of 30-Sep-2024, Unichem Laboratories has a trailing 12-month revenue of $207M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 565,263 | 439,259 | 244,169 | 249,612 |
Revenue | 207,159 | 200,205 | 162,199 | 167,497 |
EBITDA | 16,285 | 8,825 | (5,876) | 14,997 |
Net Income | (668) | (8,513) | (25,185) | 4,437 |
Total Assets | 395,495 | 380,047 | 388,917 | 437,670 |
Total Debt | 35,847 | 29,680 | 38,251 | 46,045 |
Unichem Laboratories Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Unichem Laboratories Comparisons
Industry
Financing
Details
Unichem Laboratories Competitors (2)
One of Unichem Laboratories’s 2 competitors is Mint Lifesciences Pvt, a Corporation company based in Panchkula, India.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mint Lifesciences Pvt | Corporation | Panchkula, India | ||||
Mehta API Private | Corporation | Mumbai, India |
Unichem Laboratories Patents
Unichem Laboratories Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2022410688-A1 | Recombinant protein for treating sars-cov2 disease | Pending | 16-Dec-2021 | ||
CA-3239504-A1 | Recombinant protein for sars-cov2 disease | Pending | 16-Dec-2021 | ||
EP-4447992-A1 | Recombinant protein for treating sars-cov2 disease | Pending | 16-Dec-2021 | ||
CA-3230395-A1 | Lectin-drug conjugates | Pending | 01-Oct-2021 | ||
CA-3229988-A1 | Recombinant glycan binding proteins and its use | Pending | 01-Oct-2021 | C07K14/37 |
Unichem Laboratories Signals
Unichem Laboratories Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Unichem Laboratories Investments & Acquisitions (4)
Unichem Laboratories’s most recent deal was a Merger/Acquisition with Bayshore Pharmaceuticals (US Generics Formulations Marketing and Distribution Business) for
. The deal was made on 01-Oct-2024.Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Bayshore Pharmaceuticals (US Generics Formulations Marketing and Distribution Business) | 01-Oct-2024 | Merger/Acquisition | Drug Discovery | ||
Optimus Pharma | 05-Nov-2018 | Corporate | Pharmaceuticals | ||
Niche Generics | 15-Dec-2006 | Secondary Transaction - Private | Pharmaceuticals | ||
Niche Generics | 01-Apr-2002 | Merger/Acquisition | Pharmaceuticals |
Unichem Laboratories Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Niche Generics | Pharmaceuticals | Arlesey, United Kingdom |
Unichem Laboratories ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Unichem Laboratories FAQs
-
When was Unichem Laboratories founded?
Unichem Laboratories was founded in 1944.
-
Where is Unichem Laboratories headquartered?
Unichem Laboratories is headquartered in Mumbai, India.
-
What is the size of Unichem Laboratories?
Unichem Laboratories has 2,153 total employees.
-
What industry is Unichem Laboratories in?
Unichem Laboratories’s primary industry is Pharmaceuticals.
-
Is Unichem Laboratories a private or public company?
Unichem Laboratories is a Public company.
-
What is Unichem Laboratories’s stock symbol?
The ticker symbol for Unichem Laboratories is 506690.
-
What is the current stock price of Unichem Laboratories?
As of 29-Nov-2024 the stock price of Unichem Laboratories is $9.94.
-
What is the current market cap of Unichem Laboratories?
The current market capitalization of Unichem Laboratories is $700M.
-
What is Unichem Laboratories’s current revenue?
The trailing twelve month revenue for Unichem Laboratories is $207M.
-
Who are Unichem Laboratories’s competitors?
Mint Lifesciences Pvt and Mehta API Private are competitors of Unichem Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »